Robert I. Tepper, President, R&D at MILLENNIUM PHARMACEUTICALS INC (MLNM), sold 60,000 shares at $11.84 ($712K) on 2006-10-30, disclosed to the SEC on 2006-10-31.
Scheduled sale ($712k) by President, R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.84 | 1,300 | $15K | 2.2% |
| 2 | $11.85 | 17,000 | $201K | 28.3% |
| 3 | $11.86 | 14,500 | $172K | 24.1% |
| 4 | $11.87 | 10,000 | $119K | 16.7% |
| 5 | $11.88 | 7,500 | $89K | 12.5% |
| 6 | $11.90 | 2,000 |
| $24K |
| 3.3% |
| 7 | $11.91 | 7,500 | $89K | 12.5% |
| 8 | $11.92 | 200 | $2K | 0.3% |
| Total | $11.87 avg | 60,000 | $712K | 100% |
| Filing → |
| RVMD | SELL | 2021-06-07 | $32.8M | — | Filing → |
| RLAY | SELL | 2021-01-14 | $312.2M | — | Filing → |
| JNCE | SELL | 2020-11-23 | $105K | — | Filing → |